Lv41
620 积分 2022-11-23 加入
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
2个月前
已完结
Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group
4个月前
已完结
A Multicenter Study of Clinical Presentations and Outcomes of Multiple Myeloma in Pakistan: The Real-World Analysis in a Resource-Constrained Country
6个月前
已完结
Improved survival in multiple myeloma, with a diminishing racial gap and a widening socioeconomic status gap over three decades
6个月前
已完结
Diagnosis and treatment of multiple myeloma in Germany: analysis of a nationwide multi-institutional survey
8个月前
已完结
Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 Trial
9个月前
已完结
Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma
9个月前
已完结
Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma
9个月前
已完结
The impact of induction regimen on transplant outcome in newly diagnosed multiple myeloma in the era of novel agents
9个月前
已完结
Lenalidomide in multiple myeloma: current role and future directions
9个月前
已完结
皖公网安备34019202002308
